Considering a recently featured article by NIH introducing the therapeutic effects of NSC-derived exosomes in cerebral ischemia, Creative Biolabs updates its service portfolio related to stem cell-derived exosomes. Stroke often causes cognitive impairments or even death in server cases, and ...
Read More »ExoCoBio granted first plant stem cell-derived exosome patent in the US
ExoCoBio announced that it has obtained a patent (US Application No: 17/141,693) from the US Patent and Trademark Office for a cosmetic composition...
Read More »NurExone granted US patent for technology and drug composition of Exo-PTEN, designed for treating acute spinal cord injuries
NurExone Biologic Inc, a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries, announces that the Company has received an issue...
Read More »Mursla Bio to showcase its novel tissue-specific extracellular vesicle isolation technology at ISEV2023
Mursla Bio will present its novel tissue-specific Extracellular Vesicle (EV) isolation technology, NEXPLOR, at the International Society for...
Read More »Kimera® Labs Receives FDA Phase I/IIa IND Approval For Its MSC Exosomes Human Study
Kimera® Labs Inc., the first and leading worldwide MSC exosome research lab and producer, is pleased to announce the FDA IND (Investigational New...
Read More »Evox Therapeutics Presents Progress Across its DeliverEX™ Exosome Therapeutics Platform
Six Upcoming Presentations at the Annual Meetings of the American Society of Gene and Cell Therapy (ASGCT) and of the International Society for...
Read More »EXOSOMM Looks to the Benefits of Mother’s Milk to Bring New Bioactive Ingredient for Medical Food Space
BioFoodTech start-up EXOSOMM Ltd, has explored the natural mechanisms inherent in human breastmilk to create a novel bioactive ingredient that can potentially support millions of adults with...
Read More »NanoFCM Partners with RoosterBio as an Approved Service Provider for Exosome Analysis
In this strategic partnership, RoosterBio becomes the first US-based service provider approved by NanoFCM to perform contract analytical services...
Read More »Next-Generation EV Separation: Izon Science and Agarose Bead Technologies Collaborate to Enhance Clinical Applications for Extracellular Vesicles
Recent advances in molecular biology have revealed the highly complex nature of disease development, with cancer being a prime example of a complex...
Read More »Direct Biologics Receives FDA Clearance to Initiate Phase 1b/2a Clinical Trial of ExoFlo™ in Patients with Medically Refractory Perianal Fistulizing Crohn’s Disease
ExoFlo is the first extracellular vesicle therapeutic candidate to be evaluated in this indication Direct Biologics, a late-stage biotechnology company leveraging its regenerative medicine platform using extracellular vesicles (EVs) secreted from bone marrow-derived...
Read More »